Macrophage immune activation

Macrophage immune activation refers to the process by which macrophages, key effector cells of the innate immune system, are stimulated by pathogen-associated molecules or cytokines to adopt specific functional phenotypes. Classical (M1) activation is typically driven by interferon-gamma and microbial products like LPS, resulting in a pro-inflammatory, antimicrobial state characterized by cytokine production, reactive oxygen/nitrogen species generation, and enhanced antigen presentation. Alternative (M2) activation is driven by cytokines such as IL-4 and IL-13, supporting tissue repair, immune regulation, and anti-inflammatory effects. The balance between these states determines macrophage roles in health and disease, including host defense, inflammation, cancer, fibrosis, and autoimmune conditions[1][2][3][4]. Important clarification: - “Macrophage immune activation” is a process, not a molecular target, receptor, or gene. It encompasses many pathways and surface molecules (e.g., Toll-like receptors, cytokine receptors), but should not be cataloged as a single canonical druggable target[2][3][4]. - Specific druggable targets include Toll-like receptors (e.g., TLR4), interferon-gamma receptor, colony-stimulating factor 1 receptor (CSF1R), among others embedded in the macrophage activation cascade[1][4]. - For structured databases, record this entry as an incorrect target naming and consider mapping drugs/mechanisms referenced to upstream canonical immune receptors or cytokines, not to "macrophage immune activation" itself.

Other names

Macrophage activationMacrophage polarizationMononuclear phagocyte activation

Modulation of cytokine signaling (e.g., via interferon-gamma, interleukin-4) Toll-like receptor (TLR) agonists/antagonists Inhibition or activation of specific signaling kinases (Jak/STAT, NF-κB)